Platelet and fibrinogen kinetics in the chronic myeloproliferative disorders
نویسندگان
چکیده
منابع مشابه
Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders.
Patients with myeloproliferative disorders (MPD) are known to have some abnormalities of platelet glycoproteins (Gp). Quantitative changes of the Gp Ib, IIb-IIIa, and/or their glucidic content have been reported. Since the Gp IIb-IIIa complex plays a major role in fibrinogen binding by activated platelets, we measured the platelet fibrinogen affinity in nine patients with polycythemia vera (PV)...
متن کاملChronic Myeloproliferative Disorders
JAK2, an acquired mutation of JAK2, is present in a majority of patients with polycythemia vera and to a lesser extent among patients with the other myeloproliferative disorders. We analyzed the effect of JAK2 on the expression of polycythemia rubra vera 1(PRV-1), using an in vitro model. Compared to wild-type JAK2, the presence of JAK2 increased both PRV-1 protein and mRNA levels in murine mye...
متن کاملChronic myeloproliferative disorders.
The Philadelphia chromosome-negative chronic myeloproliferative disorders (CMPD), polycythemia vera (PV), essential thrombocythemia (ET) and chronic idiopathic myelofibrosis (IMF), have overlapping clinical features but exhibit different natural histories and different therapeutic requirements. Phenotypic mimicry amongst these disorders and between them and nonclonal hematopoietic disorders, la...
متن کاملThe kinetics of clonal dominance in myeloproliferative disorders.
To study clonal evolution in myeloproliferative disorders, we used stochastic models of hematopoiesis for mouse and cat, species for which the in vivo kinetics of hematopoietic stem cells (HSCs) have been experimentally defined. We determined the consequence if 1 HSC became able to survive without the support of a microenvironmental niche while the rest of its behavior did not change. Neoplasti...
متن کاملPlatelet function and thromboxane synthesis in myeloproliferative disorders.
We have read with interest the paper of Landolfi et al,’ “Increased Thromboxane Biosynthesis in Patients With Polycythemia Vera: Evidence for Aspirin-Suppressible Platelet Activation In Vivo.” In a recent publication’ on 1 1 patients with chronic myeloproliferative disorders (CMPD), 7 with essential thrombocytosis and 4 with polycytnemia vera, we have reached a similar conclusion (with respect ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 1972
ISSN: 0008-543X,1097-0142
DOI: 10.1002/1097-0142(197212)30:6<1444::aid-cncr2820300605>3.0.co;2-l